← Leaderboards
Steve Onyeka Oghumu
Ohio State University
$4,504,894
Attributed
$4,504,894
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,504,894 · 4
By mechanism
DP1$1,974,500 · 1
R01$1,253,904 · 1
K01$715,075 · 1
R56$561,415 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Susan R Mallery$15,292,540
- Christopher M Weghorst$9,056,160
- Steven K Clinton$5,749,067
- Ming You$26,875,453
- Purnima Kumar$6,947,763
Others in their field
Other Emerging Leaders on “In Vivo”
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,216,744
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
- John Damon Chodera · Sloan-Kettering Inst Can Research$43,427,103
- Tony Moody · Duke University$34,777,314
- Alan D. Palkowitz · Indiana University Indianapolis$18,925,366
Research focus
In VivoPublic HealthCellsMouse ModelPreclinical StudyClinical ResearchMultidisciplinaryMolecularBiometryTechnologyReporterMaleResearch PersonnelCancer ChemopreventionOral Cancer PreventionOral CarcinogenesisMouth NeoplasmsOralPathway InteractionsMalignant Mouth NeoplasmMediatingBaseAffectInnovation
Grant awards (13)
The oral glucocorticoid system in oral carcinogenesis and its modulation for improved treatment outcomes$626,952
R01 · FY2025 · DE · contact PI
X chromosome inactivation in sex disparities to substance use disorder$472,500
DP1 · FY2025 · DA · contact PI
The oral glucocorticoid system in oral carcinogenesis and its modulation for improved treatment outcomes$626,952
R01 · FY2024 · DE · contact PI
X chromosome inactivation in sex disparities to substance use disorder$472,500
DP1 · FY2024 · DA · contact PI
X chromosome inactivation in sex disparities to substance use disorder$84,500
DP1 · FY2024 · DA · contact PI
X chromosome inactivation in sex disparities to substance use disorder$472,500
DP1 · FY2022 · DA · contact PI
Defining the role of the oral glucocorticoid system in oral carcinogenesis and its modulation for improved treatment outcomes$561,415
R56 · FY2021 · DE · contact PI
X chromosome inactivation in sex disparities to substance use disorder$472,500
DP1 · FY2021 · DA · contact PI
Mechanisms of Oral Cancer Inhibition by Bioactive Phytochemicals in Black Raspberries$143,015
K01 · FY2021 · CA · contact PI
Mechanisms of Oral Cancer Inhibition by Bioactive Phytochemicals in Black Raspberries$143,015
K01 · FY2020 · CA · contact PI
Mechanisms of Oral Cancer Inhibition by Bioactive Phytochemicals in Black Raspberries$143,015
K01 · FY2019 · CA · contact PI
Mechanisms of Oral Cancer Inhibition by Bioactive Phytochemicals in Black Raspberries$143,015
K01 · FY2018 · CA · contact PI
Mechanisms of Oral Cancer Inhibition by Bioactive Phytochemicals in Black Raspberries$143,015
K01 · FY2017 · CA · contact PI